Apoptosis study in thymic involution in tumour-bearing mice

International Journal of Immunopathology and Pharmacology

Volumn 11, Issue 2, 1998, Pages 49-55

  Valdez J C ^a,b   Rachid, M ^a   Gobbato, N ^a   Perdigon G ^a  

^a CENTRO DE REFERENCIA PARA LACTOBACILOS CERELA CONICET   (Argentina)

^b Inst Microbiol Dr Luis C Verna   (Argentina)

Author keywords

Apoptosis; Cancer; Involution; Thymus

Indexed keywords

DEXAMETHASONE; DNA FRAGMENT; DOXORUBICIN; ETOPOSIDE;

ANIMAL CELL; ANIMAL MODEL; APOPTOSIS; ARTICLE; COLORECTAL CARCINOMA; DRUG SENSITIVITY; FIBROSARCOMA; HISTOLOGY; IMMUNE DEFICIENCY; IN VITRO STUDY; INVOLUTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLENOMEGALY; THYMUS; THYMUS ATROPHY; TUMOR CELL; TUMOR GROWTH;

EID: 0031718481     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463209801100201     Document Type: Article

References (23)

1. Lopez D.M., R.R. Pabmabadan, L.M. Rivera, R.D. Paul, L. Herbert, C. Cray and G.A. Watson. 1986. Cytotoxic effect mechanisms involved in the immunity against mammary tumours. In Breast Cancer Scientific and Clinical Progress. M.A. Rich, J.C. Hager and D. Lopez, eds. Kluwer Acad. Publ., Boston, M:A: pp185.
2. Robin R.A. 1986. T cell response at the host-tumour interface. Biochem. Biophys. Acta 865:289.
3. Fu Y., R.D. Paul, Y. Wang and D. Lopez. 1989. Thymic involution and thymocyte phenotypic alterations induced by murine mammary adenocarcinomas. J. Immunol. 143:4.300.
4. Cohen J.J. and R.C. Ducke. 1992. Apoptosis and programmed cell death in immunity. Annu. Rev. Immunol. 10: 267.
5. Hale A.J., C.A. Smith, L.C. Sutherland, V.E.A. Stoneman, V.L. Longothornr, A.C. Culhane and G.T. Williams. 1996. Apoptosis: molecular regulation of cell death. Eur. J. Biochem. 236:1.
6. Lowe S.W., E.M. Schmitt, S.W. Smith, B.A. Osborne and T. Jacks. 1993. P53 is required for radiation-induce apoptosis in mouse thymocytes. Nature 362:847.
7. Clarke A.R., C.A. Puerdle, D,J, Harrison, R.G. Morris, C.C. Bird, M.L. Hooper and A.H. Wyllie. 1993. Thymocytes apoptosis induced by p53 dependent and independent pathways. Nature 362:849.
8. Lowe S.W., H.E. Ruley T. Jacks and D.E. Housman. 1993. P53-dependent apoptosis modulates the cytotoxicity of anticancer agents.Cell 74:957.
9. Valdez J.C., N. de Alderete, O.E. Meson, A. Sirena and G. Perdigon. 1990. Comparative activation states of tumour-associated ans peritoneal macrophages from mice bearing an induced fibrosarcoma. Immunobiol. 181: 276.
10. Dechner E.E., F.C. Long and M. Hakissian. 1988. Susceptibility to 1,2-dimethylhydrazine-induced colonic tumors and epithelial cell proliferation characteristics of F2 and reciprocal backcrosses derived from SWR/J and AKR/ parental mouse strain. Cancer. 61:478.
11. Gottschalk R.A., L.H. Boise, C.B. Thompsson and J. Quintans. 1994. Identification of immunosuppressant-induced apoptosis in a murine B-cell line and its prevention by Bcl-x but not Bcl-2. Proc. Natl. Acad Sci. USA. 91: 7350.
12. Valdez J.C. and G. Perdigon. 1992. Piroxican, indomethacin and aspirin action on a murine fibrosarcoma. Effects on tumour-associated and peritoneal macrophages. Clin Exp. Immunol. 86:315.
13. Perdigon G., J.C. Valdez, M. Rachid. 1997. Antitumour activity of yogurt. Study of possible mechanism. J. Dairy Res. 65:129.
14. Esfkind L., T. Godal, T. Grude, P.F. Marton and G.M. Hoglo. 1978. Progressive atrophy of the thymus in mice carrying Lewis lung carcinoma graft. Cancer Immunol. Immunother. 3: 207.
15. Kornbluth R.S. 1994. The immunological potential of apoptosis debris produced by tumour cells and during HIV infection. Immunol. Lett. 43:125.
16. Fauci A. 1993. Multifactorial nature of human immunodeficiency virus disease: implications for therapy. Science. 262: 1011.
17. Pelliciari C., M.G. Bottone and M. Biggiogera. 1997. Detection of apoptotic cells by Annexin V labeling at electron microscopy. Eur. J. of Histochem. 41:221
18. Strober W. and R.O. Ehrhardt. 1993. Chronic intestinal inflammation : an unexpected outcome in cytokine or T cell receptor mutant mice. Cell 75: 203.
19. Sadlack B., H. Merz, H. Schorle, A. Schimpi, A.C. Feller and I. Horak. 1993. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 75: 253.
20. Hartwell L.H. and M.B. Kastan. 1994. Cell cycle control and cancer. Science 266: 1821.
21. Shaw P., P. Bovex, S. Tardy ,R. Sahli, B. Sordat and J. Costa. 1992. Induction of apoptosis by wild-type p53 in a human colon tumour-derived cell line. Proc. Natl Acad. Sci. USA. 89: 4495.
22. Hamilton S.R. 1992. Molecular genetics of colorectal carcinoma. Cancer 70: 1216.
23. Harada M., K. Matsunga, Y. Oguchi, O. Ito, K. Tamada, G. Kimura and K. Nomoto. 1995. The involvement of transforming growth factor beta in the impaired antitumor T-cell response at the gut-associated lymphoid tissue (GALT). Cancer Res. 55: 6146.